Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Sentaur Biosciences is developing antibodies designed to specifically eliminate senescent cells by identifying novel targets on the surface of the cells.
The companys technology comes from the lab of Professor Valery Krizhanovsky, a world renown expert in the field of senescent cells at the Weizmann Institute.